Treg cell therapy for solid-organ transplantation
Validate targets, mechanisms and translational rationale before committing development resources.
Offer overview
What this offer helps you achieve
Validate targets, mechanisms and translational rationale before committing development resources.
Scientific and technical scope
Development of modified & unmodified Treg to maximize solid organ transplantation by Makoto Miyara Stages : translational research & Phase I Augmented Treg cells to achieve operational tolerance for allogeneic transplantation of solid organs - France 2030 Investments for the Future, program Grant - RHU 6 Treg Cell Therapy in Lung Transplantation - TPTREG - Hospital Clinical Research Program, national Grant - PHRC-21-0268 Treg cell therapy in kidney transplantation- TRTREG - PHRC-19-0321 Maintenance of in vitro stability of human Treg FOXP3+ cells: phenotype, epigenetics and function -Translational research program, Grant PRTS-21-0005
Capabilities mobilised
Therapeutic target discovery
Application fields
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
